30
Participants
Start Date
February 1, 2024
Primary Completion Date
December 30, 2026
Study Completion Date
June 30, 2027
Efgartigimod Alfa
Efgartigimod will be administered intravenously on Day (D)1, D8, D15, and D22 at a dose of 10 mg/kg according to the patient's weight (maximum infusion dose of 1200 mg) over approximately 1 hour for a total of 4 doses. Thymectomy will be performed on Day 9.
Shanghai Zhongshan Hospital
OTHER